Compare Bank Central Asia Tbk (BBCA) vs Brigit Biofarmaka Teknologi Tbk. (OBAT) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Bank Central Asia Tbk vs Brigit Biofarmaka Teknologi Tbk. — how do they compare? Bank Central Asia Tbk trades at Rp6,375 (market cap 774.97T, 83.21M 24h volume), while Brigit Biofarmaka Teknologi Tbk. trades at Rp242 (market cap 164.65B, 187.4K 24h volume). The key difference: Bank Central Asia Tbk is far larger — about 4706.8× Brigit Biofarmaka Teknologi Tbk.'s market cap, and Bank Central Asia Tbk is more actively traded (83.21M versus 187.4K). Which is the better fit depends on your goals.
| BBCA | OBAT | |
|---|---|---|
Market Cap | 774.97T | 164.65B |
Volume | 83.21M | 187.4K |
Lot | 832.08K | 1.87K |
Turnover | 526.91B | 44.35M |
Average Price | 6,332.47 | 236.67 |
Value | 526.91B | 44.35M |
Indicative Equilibrium Price | 6,375 | 242 |
Indicative Equilibrium Volume | 417.93K | 500 |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Bank Central Asia Tbk
PT. Bank Central Asia, Tbk (the Company) was established under the name of N.V. Perseroan Dagang Dan Industrie Semarang Knitting Factory based on notarial deed No. 38 of Raden Mas Soeprapto dated 10 August 1955, which was then changed to PT Bank Central Asia based on notarial deed No. 144 of Ridwan Suselo dated 21 May 1974.
Read more on BBCA →About Brigit Biofarmaka Teknologi Tbk.
PT. Brigit Biofarmaka Teknologi Tbk. (the Company) was established based on Notarial Deed No. 103 dated December 14, 2015 of Yoerista Arya Megasari, S.H., M.Kn., Notary in Sukoharjo. The company starts production commercially in 2018.
Read more on OBAT →
